| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $983.7M | -50.4% |
| Cost of Revenue | $343.8M | -61.9% |
| R&D Expense | $737.5M | -40.3% |
| SG&A Expense | $468.9M | -4.0% |
| Operating Income | -$566.5M | +12.1% |
| Interest Expense | $14.4M | -27.5% |
| Pre-tax Income | -$543.0M | +16.9% |
| Income Tax | $2.0M | -52.7% |
| Net Income | -$545.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $568.5M | -57.5% |
| Inventory | $41.7M | +13.7% |
| Current Assets | $1.14B | -32.8% |
| Total Assets | $1.80B | -20.4% |
| Current Liabilities | $1.64B | -33.5% |
| Total Liabilities | $2.51B | -13.1% |
| Stockholders' Equity | -$716.9M | -13.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$714.0M | -71.7% |
| Capital Expenditures | $53.8M | -39.6% |
| Investing Cash Flow | -$58.8M | +36.8% |
| Financing Cash Flow | $4.5M | -98.6% |
| Free Cash Flow | -$767.7M | -52.0% |
| +17.2% |
| EPS (Basic) | -$5.41 | +35.7% |
| EPS (Diluted) | -$5.41 | +35.7% |